SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 14 of 100
Leadership
China woos CEOs of Apple, chipmakers, pharma giants as geopolitical tensions mount: ‘The risk-reward has changed’
By
Bloomberg
March 23, 2024
Commentary
Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
By
Bill Anderson
March 21, 2024
Life
An exercise pill may soon offer the same benefits as a workout, scientists say
By
Lindsey Leake
March 18, 2024
Newsletters
How AI turbocharged the development of a new drug and what it might mean for health care
By
Diane Brady
March 14, 2024
Health
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
By
Tom Murphy
,
Matthew Perrone
and
The Associated Press
March 8, 2024
Health
Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big
By
Lindsey Leake
March 8, 2024
Health
Bayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’
By
Ryan Hogg
March 6, 2024
Retail
Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By
Niclas Rolander
and
Bloomberg
March 5, 2024
Health
Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
By
Lindsey Leake
March 5, 2024
Health
First over-the-counter birth control pill in U.S. begins shipping to stores
By
Matthew Perrone
and
The Associated Press
March 4, 2024
Finance
Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy
By
Ryan Hogg
March 3, 2024
Lifestyle
Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
By
Prarthana Prakash
February 27, 2024
Newsletters
Denmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy
By
Peter Vanham
and
Nicholas Gordon
February 27, 2024
Commentary
Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver
By
Paul Hudson
February 19, 2024
Aging Well
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers
By
Arthur Allen
and
KFF Health News
February 16, 2024
Most Popular
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith
AI
AI engineers are being deployed as consultants and getting paid $900 per hour
By
Nino Paoli